O01: Experimental Immunobiology
Chair: Caigan Du, Canada & Philip Acott, Canada
Location: MR 202 - 204, Level 2

O02: T Cell Diversity and Functional Biology
Chairs: Leslie Brent, UK & David White, Canada
Location: MR 205 - 207, Level 2

O03: Genomics and Biomarkers
Chairs: Daniel Salomon, USA & Thomas Mueller, Canada
Location: MR 211, Level 2

O04: Organ Donation and Allocation I
Chairs: Bernard Cohen, The Netherlands & Valter Duro-Garcia, Brazil
Location: MR 109 - 110, Level 1

O05: Induction Immunosuppression
Chairs: Olwyn Johnston, Canada & Arthur Matas, USA
Location: Ballroom A/B, Level 1

O06: CMV Infection
Chairs: Petra Reinke, Germany & William Rawlinson, USA
Location: MR 220 - 222, Level 2

O07: A New Century of Pediatric Transplantation?
Chairs: Susan Samuel, Canada & Anne Dipchand, Canada
Location: MR 217 - 219, Level 2

O08: Immunosuppression for Liver Transplantation
Chairs: Douglas Hanto, USA & Hans Schlitt, Germany
Location: MR 118 - 120, Level 1

O09: Optimizing Immediate Graft Function in Kidney Transplantation
Chairs: Marti Manyalich, Spain & Edward Cole, Canada
Location: Ballroom C, Level 1

O10: Mesenchymal Stem Cells and Cellular Transplantation
Chair: Mario Abbud Filho, Brazil & Michael Breimer, Sweden
Location: MR 212 - 214, Level 2

O11: Late Breaking
Chairs: Pierre Daloze, Canada & TBC
Location: MR 121 - 122, Level 1

MO01: Immune Regulation and Tolerance I
Chairs: Johann Pratschke, Austria & Leslie Brent, UK
Location: MR 202 - 204, Level 2

MO02: Clinical and Ethical Aspects of Living Donor Transplantation
Chairs: Jean Shapiro, Canada & Francis Delmonico, USA
Location: MR 109 -110, Level 1

MO03: Induction Immunosuppression
Chairs: John Najarian, USA & Diego Cantarovich, France
Location: MR 211, Level 2

MO04: Epidemiology and Clinical Outcomes
Chairs: Robert Gaston, USA & Sita Gourishankar, Canada
Location: MR 205 - 207, Level 2

MO05: Living Liver Donors and Techniques
Chairs: David Grant, Canada & Chung Mau Lo, Hong Kong
Location: MR 217 - 219, Level 2

MO06: Laboratory Immunology and Kidney Transplantation
Chairs: Ron Kerman, USA & Ian Hutchinson, USA
Location: MR 220 - 222, Level 2

MO07: Islet and Pancreas Transplantation I
Chairs: Richard Allen, Australia & Frantisek Saudek, Czech Republic
Location: MR 212 - 214, Level 2

O12: Experimental Ischemia and Reperfusion Injury
Chair: Ian Alwayn, Canada & Matthew Cooper, USA
Location: MR 220 - 222, Level2

O13: Assays to Predict Allorgraft Rejection
Chairs: Joseph Campistol, Spain & David Rush, Canada
Location: MR 217 - 219, Level 2

O14: Molecular Mechanisms of Delayed Kidney Graft Function
Chairs: Christophe Legendre, France & Shiro Takahara, Japan
Location: MR 211, Level 2

O15: Access to Treatment and Quality of Life
Chairs: Elias David-Neto, Brazil & Jeff Zaltzman, Canada
Location: MR 109 - 110, Level 1

O16: Use of mTor inhibitors and MPA I
Chairs: Klemens Budde, Germany & Josep Grinyo, Spain
Location: Ballroom A/B, Level 1

O17: Non-Viral Infections in Transplantation
Chairs: Rainaldo Bestetti, Brazil & Michael Ison, USA
Location: MR 202 -204, Level 2

O18: Biologic and Therapeutic Advances in Heart Transplantation I
Chair: Richard Kirk, UK & Marian Zembala, Poland
Location: MR 205 - 207, Level 2

O19: The Problem of Viral Hepatitis in Liver Transplantation
Chairs: Sheung-Tat Fan, Hong Kong & Norm Kneteman, Canada
Location: MR 118 -120, Level 1

O20: Options and Outcomes in the Sensitized Kidney Recipient
Chairs: Mark Stegall, USA & Steve Woodle, USA
Location: Ballroom C, Level 1

O21: Clinical Islet Transplantation
Chairs: Thierry Berney, Switzerland & Annika Tibell, Sweden
Location: MR 212 - 214, Level 2

O22: B Cells and Antibody Responses
Chairs: William Baldwin, USA & Mark Pescovitz, USA
Location: MR 202 -204, Level 2

O23: Activation and Role of T Regulatory Cells
Chairs: Megan Levings, Canada & Nader Najafian, USA
Location: MR 205 - 207, Level 2

O24: Molecular Mechanisms of Chronic Kidney Graft Injury
Chair: Sundaram Hariharan, USA & Dietmar Abendroth, Germany
Location: MR 211, Level 2

O25: Organ Donation and Allocation II
Chairs: Detlef Boesebeck, Germany & Paul Robertson, USA
Location: MR 109 -110, Level 1

O26: New Immunosuppressive Agents
Chairs: Flavio Vincenti, USA & Bjoern Nashan, Germany
Location: Ballroom A/B, Level 1

O27: BK Virus Infection
Chairs: Henrik Ekberg, Sweden & Serdar Yilmaz, Canada
Location: MR 220 - 222, Level 2

O28: Innovations in Composite Tissue Transplantation
Chairs: Jean-Michel Dubernard, France & David Cooper, USA
Location: MR 217 - 219, Level 2

O29: Outcomes of Liver Transplantation I
Chairs: John O'Grady, UK & Stephen Chung, Canada
Location: MR 118 - 120, Level 1

O30: Therapeutic Strategies for Kidney transplantation
Chairs: Anantharaman Vathsala, Singapore & Gabriel Danovitch, USA
Location: Ballroom C, Level 1

O31: Cell Therapy and Stem Cells
Chairs: Hans-Dieter Volk, Germany & Alan Colman, Singapore
Location: MR 212 - 214, Level 2

O32: Late Breaking
Chairs: Mark Meloche, USA & David Landsberg, Canada
Location: MR 121 -122, Level 1

MO08: Immune Regulation and Tolerance II
Chairs: Alvaro Pacheco-Silva, Brazil & Willem Weimar, The Netherlands
Location: MR 202 - 204, Level 2

MO09: International Trends in Organ Donation
Chairs: Helen Pilmore, New Zealand & Maher Ramzy, Egypt
Location: MR 109 - 110, Level 1

MO10: New Immunosuppressive agents
Chairs: Barry Kahan, USA & Mark Pescovitz, USA
Location: MR 211, Level 2

MO11: Societal Issues and public policy
Chairs: Felix Cantarovich, France & Haibo Wang, China
Location: MR 205 - 207, Level 2

MO12: Immunuosuppression in Liver Transplantation
Chair: Marcus Bahra, Germany & Goran Klintmalm, USA
Location: MR 217 - 219, Level 2

MO13: Clinical Strategies and Outcomes in Kidney Transplantation
Chairs: Stuart Flechner, USA & Franco Citterio, Italy
Location: MR 220 - 222, Level 2

MO14: Islet and Pancreas Transplantation II
Chairs: Helmut Arbogast, Germany & Stephen Bartlett, USA
Location: MR 212 - 214, Level 2

O33: Cellular Mechanisms of Immune Regulation
Chairs: Alice Mui, Canada & Shane Grey, Australia
Location: MR 220 - 222, Level 2

O34: Cellular Assays of the Graft Response
Chairs: Ronald Gill, USA & Hideki Ohdan, Japan
Location: MR 217 - 219, Level 2

O35: Biomarkers in Kidney Transplantation
Chairs: Peter Nickerson, Canada & Caner Suesal, Germany
Location: MR 211, Level 2

O36: Ethics, Public Policy and Economics
Chair: Mark Schnitzler, USA & Zoltan Kalo, Hungary
Location: MR 109 - 110, Level 1

O37: Use of mTor inhibitors and MPA II
Chairs: Stuart Flechner, USA & Graeme Russ, Australia
Location: Ballroom A/B, Level 1

O38: Malignancy After Transplantation
Chairs: Edward Geissler, Germany & Ryutaro Hirose, USA
Location: MR 202 - 204, Level 2

O39: Biologic and Therapeutic Advances in Heart Transplantation II
Chairs: Mario Deng, Canada & Debra Isaac, Canada
Location: MR 205 - 207, Level 2

O40: HCC and Living Donor Transplantation
Chairs: Johann Pratschke, Austria & Mark Cattral, Canada
Location: MR 118 - 120, Level 1

O41: Transplantation in ABO mismatched and sensitized recipients
Chairs: Gunnar Tyden, Sweden & James Gloor, USA
Location: Ballroom C, Level 1

O42: Clinical Pancreas Transplantation I
Chairs: John Najarian, USA & Mark Meloche, Canada
Location: MR 212 -214, Level 2

MO15: Immunological Monitoring
Chairs: Mannikam Suthanthiran, USA & Pekka Hayry, Finland
Location: MR 202 - 204, Level 2

MO16: Organ Donation, Preservation and Allocation
Chairs: Axel Rahmel, The Netherlands & Paul Robertson, USA
Location: MR 109 - 110, Level 1

MO17: CNI Minimization Strategies
Chairs: Yvon Lebranchu, France & Daniel Seron, Spain
Location: MR 211, Level 2

MO18: Innovations in Heart Transplantation I
Chair: John Kobashigawa, USA & Andreas Zuckerman, Austria
Location: MR 205 - 207, Level 2

MO19: Interventions and Outcomes in Liver Transplantation I
Chairs: Pierre Clavien, Switzerland & Andrej Buczkowski, Canada
Location: MR 217 - 219, Level 2

MO20: Xenotransplantation
Chairs: Maria Koulmanda, USA & David White, Canada
Location: MR 220 - 222, Level 2

MO21: Late Breaking
Chairs: Kareem Abu Elmagd, USA & TBC
Location: MR 212 - 214, Level 2

O43: Experimental and Human Tolerance
Chairs: Megan Sykes, USA & Maria Hernandez-Fuentes, UK
Location: MR 220 - 222, Level 2

O44: Xenotransplantation I
Chairs: Carl Groth, Sweden & Emanuele Cozzi, Italy
Location: MR 217 - 219, Level 2

O45: Molecular Diagnostics and Genomics
Chairs: Phil Dyer, UK & Andrea Zachary, USA
Location: MR 211, Level 2

O46: Epidemiology and Clinical Outcomes II
Chairs: Angela Webster, Australia & Denis Glotz, France
Location: MR 109 - 110, Level 1

O47: Clinical Trials of Immunosuppression
Chairs: Herwig-Ulf Meier Kriesche & Paul Trevillian, Australia
Location: Ballroom A/B, Level 1

O48: Advances in Surgery and Imaging
Chairs: Christopher Nguan, Canada & Richard Allen, Australia
Location: MR 202 - 204, Level 2

O49: Molecular and Clinical Aspects of Lung Transplantation
Chair: Robert Levy, Canada & Bronwyn Levvey, Australia
Location: MR 205 - 207, Level 2

O50: Intestine and Multivisceral Transplantation
Chairs: Saturo Todo, Japan & Douglas Farmer, USA
Location: MR 118 - 120, Level 1

O51: Immunological Monitoring in Kidney Transplantation
Chairs: Ferdinand Muhlbacher, Austria & Patricia Campbell, Canada
Location: MR 121 - 122, Level 1

O52: Experimental Islet Transplantation
Chairs: Leo Buhler, Switzerland & Olle Korsgren, Sweden
Location: MR 212 - 214, Level 2

O53: Clinical Role of HLA Antiobodies
Chairs: Samantha Fidler, Australia & Phil Dyer, UK
Location: MR 202 - 204, Level 2

O54: NK Cells in Graft Injury and Acceptance
Chair: Marie-Josee Hebert, Canada & Alice Mui, Canada
Location: MR 205 - 207, Level 2

O55: Molecular and Cellular Pathology of the Kidney Allograft
Chair: Kim Solez, Canada & David Rush, Canada
Location: MR 211, Level 2

O56: Epidemiology and Clinical Outcomes I
Chairs: Herwig-Ulf Meier-Kriesche, USA & Jagbir Gill, Canada
Location: MR 109 - 110, Level 1

O57: Pre-clinical immunosuppressive agents
Chairs: Randall Morris, USA & Daniel Abramowicz, Belgium
Location: Ballroom A/B, Level 1

O58: Other Viral Infections in Transplantation
Chairs: Raymund Razonable, USA & Dietmar Abendroth, Germany
Location: MR 220 - 222, Level 2

O59: Striving to Harness the Immune System in Pediatric Solid Organ Transplantation
Chairs: Richard Kirk, UK & Helen Evans, New Zealand
Location: MR 217 - 219, Level 2

O60: Outcomes of Liver Transplantation II
Chair: Sigfried Erb, Canada & Bill Wall, Canada
Location: MR 118 - 120, Level 1

O61: Bone Marrow Transplantation
Chairs: Clayton Smith, Canada & Michael Barnett, Canada
Location: Ballroom C, Level 1

O62: Clinical Pancreas Transplantation II
Chairs: James Shapiro, Canada & Steven Paraskevas, Canada
Location: MR 212 - 214, Level 2

O63: Xenotransplantation II
Chairs: Henk Schuurman, The Netherlands & Kazuhiko Yamada, USA
Location: MR 121 - 122, Level 1

MO22: Immunopharmacology
Chairs: Dirk Kuypers, Belgium & Mario Abbud Filho, Brazil
Location: MR 202 - 204, Level 2

MO23: Pediatric Organ Transplantation
Chairs: Richard Thistlethwaite, USA & Oscar Salvatierra, USA
Location: MR 109 - 110, Level 1

MO24: Cardiac and Metabolic Complication of Transplantation
Chairs: Bert Kasiske, USA & Josep Grinyo, Spain
Location: MR 211, Level 2

MO25: Innovations in Heart Transplantation II
Chairs: Abbas Khani-Hanjani, Canada & Stephan Schueler, UK
Location: MR 205 - 207, Level 2

MO26: Interventions and Outcomes in Liver Transplantation II
Chairs: Ian Alwayn, Canada & Steve Lynch, Australia
Location: MR 217 - 219, Level 2

MO27: Experimental and Clinical Lung Transplantation
Chair: Annette Boehler, Switzerland & Martin Strueber, Germany
Location: MR 220 - 222, Level 2

MO28: Stem Cells and Cellular Transplantation
Chairs: Igor Sauer, Germany & Clyde Barker, USA
Location: MR 212 - 214, Level 2